CD40-CD40L interactions induce chemokine expression by human microglia: Implications for human immunodeficiency virus encephalitis and multiple sclerosis

American Journal of Pathology

Volumn 160, Issue 2, 2002, Pages 559-567

  D'Aversa, Teresa G ^a   Weidenheim, Karen M ^a   Berman, Joan W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CHEMOKINE; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; COMPLEMENT ACTIVATION; ENCEPHALITIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOLECULAR INTERACTION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

EID: 0036173719     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64875-4     Document Type: Article

References (61)

1. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40
2. Impaired T cellmediated macrophage activation in CD40 ligand-deficient mice
3. Molecular and biological characterization of a murine ligand for CD40
4. Identification of a source of biologically active CD40 ligand
5. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells
6. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
7. Analysis of CD40-CD40 ligand interactions in the regulation of human B cell function
8. Functional role of CD40 and its ligand
9. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
10. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis
11. Current perspectives of neuroimmunologic disease: Multiple sclerosis and experimental allergic encephalomyelitis (1,2)
12. Further lymphocyte characterization in the central nervous system in multiple sclerosis
13. Characterization and distribution of lymphocyte subpopulations in multiple sclerosis plaques versus autoimmune demyelinating lesions
14. Localization of simian immunodeficiency virus in the central nervous system of rhesus monkeys
15. Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus
16. Immunocytochemical identification of T-cells in HIV-1 encephalitis: Implications for pathogenesis of CNS disease
17. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factorbeta
18. CD40 engagement stimulates IL-12 p70 production by human microglial cells basis for Th1 polarization in the CNS
19. Chemokines
20. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells
21. Microglia a sensor for pathological events in the CNS
22. Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia
23. MIP-1 alpha and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation
24. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
25. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: An immunohistochemical and in situ hybridization study
26. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions
27. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia
28. Chemokine and chemokine-receptor expression in human glial elements: Induction by the HIV protein, Tat, and chemokine autoregulation
29. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
30. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo
31. A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket
32. The initiation of the microglial response
33. Bone marrow-derived elements in the central nervous system: An immunohistochemical and ultrastructural survey of rat chimeras
34. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
35. Bone marrow derived elements and resident microglia in brain inflammation
36. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage
37. Activation of microglial cells by the CD40 pathway: Relevance to multiple sclerosis
38. CD40 engagement stimulates IL-12 p70 production by human microglial cells basis for Th1 polarization in the CNS
39. Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factorbeta
40. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease
41. Enhanced interferon-gamma by CD8+ CD28-lymphocytes from HIV+ patients
42. Cytokine regulation of CD40 expression in fetal human astrocyte cultures
43. Early reduction of the over-expression of CD40L, OX40 and Fas on T cells in HIV-1 infection during triple anti-retroviral therapy: Possible implications for lymphocyte traffic and functional recovery
44. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
45. Chemokines and receptors in HIV encephalitis
46. Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat
47. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis
48. Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis
49. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis
50. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1 alpha and IP-10 are expressed in demyelinating brain lesions
51. CC CKR5: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1
52. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates
53. Identification of a major co-receptor for primary isolates of HIV-1
54. A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
55. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
56. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells
57. Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: Implications for recruitment of leukocytes into brain and lymph nodes
58. Role of HIV-1 Tat and CC chemokine MIP-1 alpha in the pathogenesis of HIV associated central nervous system disorders
59. Chemokine receptor expression on resident and inflammatory cells in the brain of macaques with simian immunodeficiency virus encephalitis
60. Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis
61. Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells